ALI/ARDS Clinical Sub-phenotyping Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ALI/ARDS Clinical Sub-phenotyping Study — Stella

Recruiting

Back to Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) trials

Trial locations(1 site)

China

Jingen Xia, Beijing

Key details

Sponsor

China-Japan Friendship Hospital

Enrollment target

~1,500 participants

Started

December 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov